Cardiometabolic
The next cardiometabolic battleground is ultra-processed food
From Indonesia and the United Kingdom to the United States and India, governments are increasingly targeting ultra-processed foods through warning labels, advertising restrictions, reformulation policies and potential taxes. The shift reflects growing recognition that cardiometabolic disease cannot be solved through healthcare alone.
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Physical activity continues to strengthen its case as a cross-disease prevention strategy
Can cortisol become the next target in type 2 diabetes?
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Europe’s Safe Hearts Plan Makes Prevention a Political Test
AI Diabetes Tools Need Infrastructure Before Scale
Diabetes Tech Moves From Optional Add-On to Earlier Care
Obesity Care Starts Moving Beyond BMI
Canada’s Generic Semaglutide Approval Tests GLP-1 Affordability
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.